Published in J Breath Res on October 13, 2014
Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs. Science (1999) 7.54
Oxidative stress and disuse muscle atrophy. J Appl Physiol (1985) (2007) 2.53
The mammalian carboxylesterases: from molecules to functions. Annu Rev Pharmacol Toxicol (1998) 2.40
Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology. Proc Nutr Soc (2004) 2.09
Hydrocarbon gases produced during in vitro peroxidation of polyunsaturated fatty acids and decomposition of preformed hydroperoxides. Lipids (1977) 2.04
ISOPRENE EMISSION FROM PLANTS. Annu Rev Plant Physiol Plant Mol Biol (2001) 1.95
A unified mechanism of action for volatile isoprenoids in plant abiotic stress. Nat Chem Biol (2009) 1.93
Enzymatic synthesis of isoprene from dimethylallyl diphosphate in aspen leaf extracts. Plant Physiol (1991) 1.82
Human carboxylesterase isozymes: catalytic properties and rational drug design. Drug Metab Pharmacokinet (2006) 1.75
Human aldehyde dehydrogenases: potential pathological, pharmacological, and toxicological impact. J Biochem Mol Toxicol (2003) 1.64
The potential of the hydrocarbon breath test as a measure of lipid peroxidation. Free Radic Biol Med (1994) 1.48
A review of the volatiles from the healthy human body. J Breath Res (2014) 1.46
TD-GC-MS analysis of volatile metabolites of human lung cancer and normal cells in vitro. Cancer Epidemiol Biomarkers Prev (2010) 1.46
Release of volatile organic compounds (VOCs) from the lung cancer cell line CALU-1 in vitro. Cancer Cell Int (2008) 1.40
Lipid oxidation. Prog Lipid Res (1980) 1.40
Physiological modeling of isoprene dynamics in exhaled breath. J Theor Biol (2010) 1.29
Measurement and biological significance of the volatile sulfur compounds hydrogen sulfide, methanethiol and dimethyl sulfide in various biological matrices. J Chromatogr B Analyt Technol Biomed Life Sci (2009) 1.26
Assessment, origin, and implementation of breath volatile cancer markers. Chem Soc Rev (2013) 1.23
Release of volatile organic compounds from the lung cancer cell line NCI-H2087 in vitro. Anticancer Res (2009) 1.18
Distribution of messenger RNAs for aldehyde dehydrogenase 1, aldehyde dehydrogenase 2, and aldehyde dehydrogenase 5 in human tissues. J Investig Med (1996) 1.16
Kinetics and specificity of human liver aldehyde dehydrogenases toward aliphatic, aromatic, and fused polycyclic aldehydes. Biochemistry (1996) 1.16
Mechanism of oxidative stress in skeletal muscle atrophied by immobilization. Am J Physiol (1993) 1.16
Breath isoprene--aspects of normal physiology related to age, gender and cholesterol profile as determined in a proton transfer reaction mass spectrometry study. Clin Chem Lab Med (2008) 1.15
Characterization of three isoenzymes of rat alcohol dehydrogenase. Tissue distribution and physical and enzymatic properties. Eur J Biochem (1987) 1.15
Molecular analysis of volatile metabolites released specifically by Staphylococcus aureus and Pseudomonas aeruginosa. BMC Microbiol (2012) 1.11
Physical and enzymatic properties of a class II alcohol dehydrogenase isozyme of human liver: pi-ADH. Biochemistry (1984) 1.11
Isoprene biosynthesis in Bacillus subtilis via the methylerythritol phosphate pathway. J Nat Prod (2000) 1.04
Effect of oxygen on breath markers of oxidative stress. Eur Respir J (2003) 1.04
Blood and breath levels of selected volatile organic compounds in healthy volunteers. Analyst (2013) 1.02
Analysis of volatile organic compounds (VOCs) in the headspace of NCI-H1666 lung cancer cells. Cancer Biomark (2010) 1.00
Potential applications of breath isoprene as a biomarker in modern medicine: a concise overview. Wien Klin Wochenschr (2005) 1.00
Aldehyde dehydrogenase activity promotes survival of human muscle precursor cells. J Cell Mol Med (2011) 0.99
Breath isoprene: muscle dystrophy patients support the concept of a pool of isoprene in the periphery of the human body. Biochem Biophys Res Commun (2012) 0.93
Acid-catalyzed formation of isoprene from a mevalonate-derived product using a rat liver cytosolic fraction. J Biol Chem (1985) 0.93
Analysis of volatile organic compounds released from human lung cancer cells and from the urine of tumor-bearing mice. Cancer Cell Int (2012) 0.92
Breath alkanes as a marker of oxidative stress in different clinical conditions. Free Radic Biol Med (2000) 0.92
Characterization of volatile metabolites taken up by or released from Streptococcus pneumoniae and Haemophilus influenzae by using GC-MS. Microbiology (2012) 0.91
Release and uptake of volatile organic compounds by human hepatocellular carcinoma cells (HepG2) in vitro. Cancer Cell Int (2013) 0.90
3-Heptanone as a potential new marker for valproic acid therapy. J Breath Res (2009) 0.90
Assessment of the exhalation kinetics of volatile cancer biomarkers based on their physicochemical properties. J Breath Res (2014) 0.90
Urine 4-heptanone: a beta-oxidation product of 2-ethylhexanoic acid from plasticisers. Clin Chim Acta (2001) 0.89
Antioxidant vitamin supplementation in Crohn's disease decreases oxidative stress. a randomized controlled trial. Am J Gastroenterol (2003) 0.87
Effect of dietary vitamin E on expiration of pentane and ethane by the rat. Lipids (1977) 0.87
Blood and breath profiles of volatile organic compounds in patients with end-stage renal disease. BMC Nephrol (2014) 0.85
Mitochondrial DNA damage via augmented oxidative stress regulates endoplasmic reticulum stress and autophagy: crosstalk, links and signaling. PLoS One (2013) 0.84
Physiological correlates of musth: lipid metabolites and chemical composition of exudates. Physiol Behav (1999) 0.84
Measurement of isoprene solubility in water, human blood and plasma by multiple headspace extraction gas chromatography coupled with solid phase microextraction. J Breath Res (2011) 0.84
Comparative analyses of volatile organic compounds (VOCs) from patients, tumors and transformed cell lines for the validation of lung cancer-derived breath markers. J Breath Res (2014) 0.83
Breath isoprene in patients with heart failure. Eur J Heart Fail (2001) 0.83
Bacterial sources and sinks of isoprene, a reactive atmospheric hydrocarbon. Environ Microbiol (2000) 0.82
Pioglitazone has direct effects on insulin sensitivity and intracellular lipid content in L6 skeletal muscle cells. Horm Metab Res (2010) 0.81
Human blood and plasma partition coefficients for C4-C8 n-alkanes, isoalkanes, and 1-alkenes. Int J Toxicol (2012) 0.81
Analysis of exhaled breath for disease detection. Annu Rev Anal Chem (Palo Alto Calif) (2014) 0.81
Blood isoprene concentrations in humans and in some animal species. Biochem Med Metab Biol (1992) 0.80
The metabolism of nonane, a JP-8 jet fuel component, by human liver microsomes, P450 isoforms and alcohol dehydrogenase and inhibition of human P450 isoforms by JP-8. Chem Biol Interact (2005) 0.78
Distribution of carboxylesterase activities in different tissues of albino rats. Comp Biochem Physiol B (1971) 0.77
A comparative study of aldehyde dehydrogenase and alcohol dehydrogenase activities in crucian carp and three other vertebrates: apparent adaptations to ethanol production. J Comp Physiol B (1988) 0.77
The metabolism of n-nonane in male Fischer 344 rats. Chemosphere (1995) 0.76
Noninvasive detection of lung cancer by analysis of exhaled breath. BMC Cancer (2009) 1.99
Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry. Clin Chem Lab Med (2009) 1.64
Human exhaled air analytics: biomarkers of diseases. Biomed Chromatogr (2007) 1.56
Strong corruption of electrocardiograms caused by cardiopulmonary resuscitation reduces efficiency of two-channel methods for removing motion artefacts in non-shockable rhythms. Resuscitation (2009) 1.54
Volatile organic compounds of lung cancer and possible biochemical pathways. Chem Rev (2012) 1.54
TD-GC-MS analysis of volatile metabolites of human lung cancer and normal cells in vitro. Cancer Epidemiol Biomarkers Prev (2010) 1.46
Release of volatile organic compounds (VOCs) from the lung cancer cell line CALU-1 in vitro. Cancer Cell Int (2008) 1.40
Altered electrical activity of fibrillation process following thrombolytic therapy in out-of-hospital cardiac arrest patients with sustained ventricular fibrillation. Med Hypotheses (2006) 1.37
Physiological modeling of isoprene dynamics in exhaled breath. J Theor Biol (2010) 1.29
Assessment, origin, and implementation of breath volatile cancer markers. Chem Soc Rev (2013) 1.23
Measurement of endogenous acetone and isoprene in exhaled breath during sleep. Physiol Meas (2012) 1.21
Implementation and interpretation of hydrogen breath tests. J Breath Res (2008) 1.21
Release of volatile organic compounds from the lung cancer cell line NCI-H2087 in vitro. Anticancer Res (2009) 1.18
Suitability of different polymer bags for storage of volatile sulphur compounds relevant to breath analysis. J Chromatogr B Analyt Technol Biomed Life Sci (2008) 1.15
Breath isoprene--aspects of normal physiology related to age, gender and cholesterol profile as determined in a proton transfer reaction mass spectrometry study. Clin Chem Lab Med (2008) 1.15
A mathematical model for breath gas analysis of volatile organic compounds with special emphasis on acetone. J Math Biol (2011) 1.15
Molecular analysis of volatile metabolites released specifically by Staphylococcus aureus and Pseudomonas aeruginosa. BMC Microbiol (2012) 1.11
Breath biomarkers for lung cancer detection and assessment of smoking related effects--confounding variables, influence of normalization and statistical algorithms. Clin Chim Acta (2010) 1.07
Comparison of the dissolution of metaxalone tablets (Skelaxin) using USP Apparatus 2 and 3. AAPS PharmSciTech (2004) 1.07
Hypoxia up-regulates the angiogenic cytokine secretoneurin via an HIF-1alpha- and basic FGF-dependent pathway in muscle cells. FASEB J (2007) 1.05
Temporal profiling of human urine VOCs and its potential role under the ruins of collapsed buildings. Toxicol Mech Methods (2012) 1.04
Analysis of exhaled breath from smokers, passive smokers and non-smokers by solid-phase microextraction gas chromatography/mass spectrometry. Biomed Chromatogr (2009) 1.03
Blood and breath levels of selected volatile organic compounds in healthy volunteers. Analyst (2013) 1.02
Analysis of volatile organic compounds (VOCs) in the headspace of NCI-H1666 lung cancer cells. Cancer Biomark (2010) 1.00
Ion mobility spectrometry for detection of skin volatiles. J Chromatogr B Analyt Technol Biomed Life Sci (2012) 0.99
Secretoneurin, an angiogenic neuropeptide, induces postnatal vasculogenesis. Circulation (2004) 0.97
Removal of CPR artifacts from the ventricular fibrillation ECG by adaptive regression on lagged reference signals. IEEE Trans Biomed Eng (2008) 0.93
Breath acetone monitoring by portable Si:WO3 gas sensors. Anal Chim Acta (2012) 0.91
Characterization of volatile metabolites taken up by or released from Streptococcus pneumoniae and Haemophilus influenzae by using GC-MS. Microbiology (2012) 0.91
Compounds enhanced in a mass spectrometric profile of smokers' exhaled breath versus non-smokers as determined in a pilot study using PTR-MS. J Breath Res (2008) 0.90
Release and uptake of volatile organic compounds by human hepatocellular carcinoma cells (HepG2) in vitro. Cancer Cell Int (2013) 0.90
The effects of nifedipine on ventricular fibrillation mean frequency in a porcine model of prolonged cardiopulmonary resuscitation. Anesth Analg (2003) 0.90
Stability of selected volatile breath constituents in Tedlar, Kynar and Flexfilm sampling bags. Analyst (2013) 0.90
Optimization of sampling parameters for collection and preconcentration of alveolar air by needle traps. J Breath Res (2012) 0.89
Detecting ventricular fibrillation by time-delay methods. IEEE Trans Biomed Eng (2007) 0.88
Application of ion mobility spectrometry for the detection of human urine. Anal Bioanal Chem (2010) 0.87
Improved pre-concentration and detection methods for volatile sulphur breath constituents. J Chromatogr B Analyt Technol Biomed Life Sci (2009) 0.87
Permeation profiles of potential urine-borne biomarkers of human presence over brick and concrete. Analyst (2012) 0.86
Blood and breath profiles of volatile organic compounds in patients with end-stage renal disease. BMC Nephrol (2014) 0.85
Measurement of isoprene solubility in water, human blood and plasma by multiple headspace extraction gas chromatography coupled with solid phase microextraction. J Breath Res (2011) 0.84
Preparation and characterization of microporous fibers for sample preparation and LC-MS determination of drugs. J Sep Sci (2009) 0.84
Comparative analyses of volatile organic compounds (VOCs) from patients, tumors and transformed cell lines for the validation of lung cancer-derived breath markers. J Breath Res (2014) 0.83
Temporally resolved fluctuation analysis of sleep ECG. J Biol Phys (2007) 0.83
Reliability of old and new ventricular fibrillation detection algorithms for automated external defibrillators. Biomed Eng Online (2005) 0.82
Breath gas analysis for estimating physiological processes using anesthetic monitoring as a prototypic example. Conf Proc IEEE Eng Med Biol Soc (2011) 0.82
Breath analysis for in vivo detection of pathogens related to ventilator-associated pneumonia in intensive care patients: a prospective pilot study. J Breath Res (2015) 0.81
Human blood and plasma partition coefficients for C4-C8 n-alkanes, isoalkanes, and 1-alkenes. Int J Toxicol (2012) 0.81
Proton transfer reaction-mass spectrometry applications in medical research. J Breath Res (2009) 0.81
Near real-time VOCs analysis using an aspiration ion mobility spectrometer. J Breath Res (2013) 0.81
Simulation of interaction between two non-depolarizing muscle relaxants: generation of an additive or a supra-additive neuromuscular block. J Pharmacokinet Pharmacodyn (2004) 0.80
The role of methane in mammalian physiology-is it a gasotransmitter? J Breath Res (2015) 0.80
CPR artifact removal in ventricular fibrillation ECG signals using Gabor multipliers. IEEE Trans Biomed Eng (2009) 0.80
Postprandial triglyceride-rich lipoproteins induce hepatic insulin resistance in HepG2 cells independently of their receptor-mediated cellular uptake. Mol Cell Endocrinol (2011) 0.79
Modeling of twitch fade based on slow interaction of nondepolarizing muscle relaxants with the presynaptic receptors. J Pharmacokinet Pharmacodyn (2006) 0.78
Modeling-based determination of physiological parameters of systemic VOCs by breath gas analysis: a pilot study. J Breath Res (2015) 0.78
Determination of sevoflurane and its metabolite hexafluoroisopropanol by direct injection of human plasma into gas chromatography-tandem mass spectrometry. J Chromatogr A (2011) 0.78
Competition between acetylcholine and a nondepolarizing muscle relaxant for binding to the postsynaptic receptors at the motor end plate: simulation of twitch strength and neuromuscular block. J Pharmacokinet Pharmacodyn (2003) 0.78
Multi-capillary-column proton-transfer-reaction time-of-flight mass spectrometry. J Chromatogr A (2013) 0.77
Application of GC-MS with a SPME and thermal desorption technique for determination of dimethylamine and trimethylamine in gaseous samples for medical diagnostic purposes. J Breath Res (2010) 0.77
Diagnosing lactose malabsorption in children: difficulties in interpreting hydrogen breath test results. J Breath Res (2016) 0.77
Temperature-programmed gas chromatography linear retention indices of all C4-C30 monomethylalkanes on methylsilicone OV-1 stationary phase. Contribution towards a better understanding of volatile organic compounds in exhaled breath. J Chromatogr A (2007) 0.76
Detection of potential chronic kidney disease markers in breath using gas chromatography with mass-spectral detection coupled with thermal desorption method. J Chromatogr A (2013) 0.76
Simulation of the reversal of neuromuscular block by sequestration of the free molecules of the muscle relaxant. J Pharmacokinet Pharmacodyn (2007) 0.76
Detection of volatile malodorous compounds in breath: current analytical techniques and implications in human disease. Bioanalysis (2014) 0.76
On the importance of developing a new generation of breath tests for Helicobacter pylori detection. J Breath Res (2015) 0.76
First human exposure to Org 25969. Anesthesiology (2006) 0.75
Non-(13)CO2 targeted breath tests: a feasibility study. J Breath Res (2014) 0.75
ABA-Cloud: support for collaborative breath research. J Breath Res (2013) 0.75
Volume of the effect compartment in simulations of neuromuscular block. Theor Biol Med Model (2005) 0.75
A Compendium of Volatile Organic Compounds (VOCs) Released By Human Cell Lines. Curr Med Chem (2016) 0.75
Prediction of blood:air and fat:air partition coefficients of volatile organic compounds for the interpretation of data in breath gas analysis. J Breath Res (2016) 0.75
Product ion distributions for the reactions of NO(+) with some physiologically significant volatile organosulfur and organoselenium compounds obtained using a selective reagent ionization time-of-flight mass spectrometer. Rapid Commun Mass Spectrom (2014) 0.75
Evaluation of septa quality for automatic SPME-GC-MS trace analysis. J Chromatogr Sci (2012) 0.75
Modeling of breath methane concentration profiles during exercise on an ergometer. J Breath Res (2016) 0.75
The relationship between twitch depression and twitch fade during neuromuscular block produced by vecuronium: correlation with the release of acetylcholine. Theor Biol Med Model (2007) 0.75
Analysis of volatile organic compounds liberated and metabolised by human umbilical vein endothelial cells (HUVEC) in vitro. Cell Biochem Biophys (2015) 0.75
Time to maximum effect site concentration. Anesthesiology (2004) 0.75
Product ion distributions for the reactions of NO(+) with some physiologically significant aldehydes obtained using a SRI-TOF-MS instrument. Int J Mass Spectrom (2014) 0.75
Monitoring of selected skin-borne volatile markers of entrapped humans by selective reagent ionization time of flight mass spectrometry in NO+ mode. Anal Chem (2014) 0.75
Three-dimensional dental arch and palatal form changes after extraction and nonextraction treatment. Part 3. Transversal and sagittal palatal form. Am J Orthod Dentofacial Orthop (2004) 0.75
Application of filtering methods for removal of resuscitation artifacts from human ECG signals. Conf Proc IEEE Eng Med Biol Soc (2008) 0.75
Axiographic findings in patients undergoing orthodontic treatment with and without premolar extractions. Eur J Orthod (2004) 0.75
Association of the canine guidance angle with maxillary and mandibular intercanine widths and anterior alignment relapse: Extraction vs nonextraction treatment. Am J Orthod Dentofacial Orthop (2008) 0.75
Three-dimensional dental arch and palatal form changes after extraction and nonextraction treatment. Part 1. Arch length and area. Am J Orthod Dentofacial Orthop (2004) 0.75
Symptomatic upper extremity deep vein thrombosis as a complication of ambulatory blood pressure monitoring. Thromb Haemost (2008) 0.75